首页 > 最新文献

International Journal of Endocrinology最新文献

英文 中文
Precision Screening for MetS: The Role of Derived Lipid Indicators in Chinese Populations. met的精确筛选:衍生脂质指标在中国人群中的作用。
IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-29 eCollection Date: 2025-01-01 DOI: 10.1155/ije/9990629
Jiayu Zhou, Weifang Dai, Weina Xu, Shanna Liu, Qingli Zhou

Metabolic syndrome (MetS) is a significant public health concern among middle-aged and elderly populations in China. This study evaluates the predictive value of four derived lipid indicators-lipid accumulation product (LAP), visceral adiposity index (VAI), triglyceride-glucose (TyG) index, and Chinese visceral adiposity index (CVAI) for MetS in Chinese adults aged ≥ 45 years. Data were sourced from the 2015 China Health and Retirement Longitudinal Study (CHARLS). Participants were classified according to the International Diabetes Federation (IDF), National Cholesterol Education Program (NCEP ATP III, 2001), and China's 2020 Guidelines for Type 2 Diabetes Prevention and Treatment. Multivariate logistic regression and ROC curve analyses assessed the predictive performance of these indicators. Results demonstrated that LAP and CVAI showed the highest predictive accuracy for MetS under the IDF criteria (AUC = 0.903), while LAP and TyG were most effective under the NCEP ATP III and China 2020 guidelines (AUC = 0.860). Subgroup analyses revealed sex- and age-specific variations in indicator effectiveness. This study suggests that derived indicators, particularly LAP and TyG, enhance the screening and management of MetS in middle-aged and elderly Chinese populations. These findings support the adoption of LAP and TyG in clinical practice to improve early detection and targeted intervention strategies.

代谢综合征(MetS)是中国中老年人群中一个重要的公共卫生问题。本研究评估了脂质累积积(LAP)、内脏脂肪指数(VAI)、甘油三酯-葡萄糖指数(TyG)和中国内脏脂肪指数(CVAI)四种衍生脂质指标对年龄≥45岁的中国成年人MetS的预测价值。数据来源于2015年中国健康与退休纵向研究(CHARLS)。参与者根据国际糖尿病联合会(IDF)、国家胆固醇教育计划(NCEP ATP III, 2001)和中国2020年2型糖尿病预防和治疗指南进行分类。多变量逻辑回归和ROC曲线分析评估了这些指标的预测性能。结果表明,在IDF标准下,LAP和CVAI对MetS的预测精度最高(AUC = 0.903),而在NCEP ATP III和中国2020指南下,LAP和TyG最有效(AUC = 0.860)。亚组分析揭示了指标有效性的性别和年龄特异性差异。本研究表明,衍生指标,特别是LAP和TyG,可以增强中国中老年人群MetS的筛查和管理。这些发现支持在临床实践中采用LAP和TyG来改善早期发现和有针对性的干预策略。
{"title":"Precision Screening for MetS: The Role of Derived Lipid Indicators in Chinese Populations.","authors":"Jiayu Zhou, Weifang Dai, Weina Xu, Shanna Liu, Qingli Zhou","doi":"10.1155/ije/9990629","DOIUrl":"10.1155/ije/9990629","url":null,"abstract":"<p><p>Metabolic syndrome (MetS) is a significant public health concern among middle-aged and elderly populations in China. This study evaluates the predictive value of four derived lipid indicators-lipid accumulation product (LAP), visceral adiposity index (VAI), triglyceride-glucose (TyG) index, and Chinese visceral adiposity index (CVAI) for MetS in Chinese adults aged ≥ 45 years. Data were sourced from the 2015 China Health and Retirement Longitudinal Study (CHARLS). Participants were classified according to the International Diabetes Federation (IDF), National Cholesterol Education Program (NCEP ATP III, 2001), and China's 2020 Guidelines for Type 2 Diabetes Prevention and Treatment. Multivariate logistic regression and ROC curve analyses assessed the predictive performance of these indicators. Results demonstrated that LAP and CVAI showed the highest predictive accuracy for MetS under the IDF criteria (AUC = 0.903), while LAP and TyG were most effective under the NCEP ATP III and China 2020 guidelines (AUC = 0.860). Subgroup analyses revealed sex- and age-specific variations in indicator effectiveness. This study suggests that derived indicators, particularly LAP and TyG, enhance the screening and management of MetS in middle-aged and elderly Chinese populations. These findings support the adoption of LAP and TyG in clinical practice to improve early detection and targeted intervention strategies.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2025 ","pages":"9990629"},"PeriodicalIF":2.3,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12588751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Sexual Dysfunction in Patients With Chronic Prostatitis. 慢性前列腺炎患者性功能障碍的患病率。
IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-29 eCollection Date: 2025-01-01 DOI: 10.1155/ije/8530481
Shahryar Zeighami, Sanaz Amiri, Leila Jamali, Alireza Shokrgozar, Javad Khalatbari, Iman Shamohammadi, Mehdi Nejat, Zahra Azadian, Fatemeh Azadian

Introduction: The prostatitis syndrome is one of the most common entities encountered in urologic practice. One of the most common problems that patients with chronic prostatitis typically face is sexual dysfunction. This study aimed to determine the prevalence of sexual dysfunction in patients with chronic prostatitis.

Methods: The present study is a cross-sectional study on 400 patients aged 18 to 50 years who were treated for chronic prostatitis and for whom more than three months had passed since the onset of their prostatitis and treatment. The patients were included in the study through a census. The Changes in Sexual Functioning Questionnaire Short Form (CSFQ-14) was used to assess the sexual functioning status of the patients.

Result: In this study, a total of 400 patients who had referred to the medical centers and hospitals affiliated with Shiraz University of Medical Sciences in 2024 due to chronic prostatitis were examined. The mean age of the patients was 40.83 ± 8.77. The mean sexual function score among patients with chronic prostatitis was 35.62 ± 8, with 89.2% of these individuals exhibiting signs of sexual dysfunction. Based on the results of this study, there was a significant relationship between sexual dysfunction and the type of relationship with the spouse (p=0.01).

Conclusion: According to the findings of this study, sexual dysfunction is a common complication in men with chronic prostatitis. Most patients had a cold and weak relationship with their spouse.

简介:前列腺炎综合征是泌尿外科实践中最常见的疾病之一。慢性前列腺炎患者通常面临的最常见问题之一是性功能障碍。本研究旨在确定慢性前列腺炎患者性功能障碍的患病率。方法:本研究是一项横断面研究,对400例年龄在18至50岁之间的慢性前列腺炎患者进行研究,这些患者自前列腺炎发病和治疗以来已经超过三个月。这些患者是通过人口普查纳入研究的。采用《性功能变化问卷简表》(CSFQ-14)评估患者的性功能状况。结果:本研究共对2024年因慢性前列腺炎转诊到设拉子医科大学附属医院的400例患者进行了检查。患者平均年龄40.83±8.77岁。慢性前列腺炎患者的平均性功能评分为35.62±8分,有性功能障碍的患者占89.2%。根据本研究结果,性功能障碍与配偶关系类型有显著关系(p=0.01)。结论:性功能障碍是男性慢性前列腺炎的常见并发症。大多数患者与配偶的关系冷淡而脆弱。
{"title":"Prevalence of Sexual Dysfunction in Patients With Chronic Prostatitis.","authors":"Shahryar Zeighami, Sanaz Amiri, Leila Jamali, Alireza Shokrgozar, Javad Khalatbari, Iman Shamohammadi, Mehdi Nejat, Zahra Azadian, Fatemeh Azadian","doi":"10.1155/ije/8530481","DOIUrl":"10.1155/ije/8530481","url":null,"abstract":"<p><strong>Introduction: </strong>The prostatitis syndrome is one of the most common entities encountered in urologic practice. One of the most common problems that patients with chronic prostatitis typically face is sexual dysfunction. This study aimed to determine the prevalence of sexual dysfunction in patients with chronic prostatitis.</p><p><strong>Methods: </strong>The present study is a cross-sectional study on 400 patients aged 18 to 50 years who were treated for chronic prostatitis and for whom more than three months had passed since the onset of their prostatitis and treatment. The patients were included in the study through a census. The Changes in Sexual Functioning Questionnaire Short Form (CSFQ-14) was used to assess the sexual functioning status of the patients.</p><p><strong>Result: </strong>In this study, a total of 400 patients who had referred to the medical centers and hospitals affiliated with Shiraz University of Medical Sciences in 2024 due to chronic prostatitis were examined. The mean age of the patients was 40.83 ± 8.77. The mean sexual function score among patients with chronic prostatitis was 35.62 ± 8, with 89.2% of these individuals exhibiting signs of sexual dysfunction. Based on the results of this study, there was a significant relationship between sexual dysfunction and the type of relationship with the spouse (<i>p</i>=0.01).</p><p><strong>Conclusion: </strong>According to the findings of this study, sexual dysfunction is a common complication in men with chronic prostatitis. Most patients had a cold and weak relationship with their spouse.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2025 ","pages":"8530481"},"PeriodicalIF":2.3,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12588745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship Between Triglyceride-Glucose Index and Handgrip Strength in the Midlife and Elderly Population: Evidence From a Chinese Cohort. 甘油三酯-葡萄糖指数与中老年人群握力的关系:来自中国队列的证据。
IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-24 eCollection Date: 2025-01-01 DOI: 10.1155/ije/8838404
Zhaoliang Zhang, Yunfei Xu, Liehui Yao, Tao Ma, Liming Zhou

Aims: At present, only a limited number of studies have investigated the association between muscle strength and insulin resistance. This study aimed to investigate the relationship between handgrip strength, a recognized indicator of overall muscle function and healthy aging, and triglyceride-glucose (TyG)-based indicators, including the TyG index, TyG-body mass index (TyG-BMI), TyG-waist circumference (TyG-WC), and TyG-waist-to-height ratio (TyG-WHtR), among middle-aged and older Chinese adults.

Methods: We utilized a cohort from the China Health and Retirement Longitudinal Study (CHARLS) collected in 2011 and 2015, comprising a total of 3318 participants. Handgrip strength was assessed using absolute handgrip strength (measured by dynamometers), relative handgrip strength (absolute handgrip strength standardized by BMI), and defined weak handgrip strength. The relationships between the TyG index and its derived measures (TyG-BMI, TyG-WC, and TyG-WHtR) and different grip strength outcomes were examined using both multivariable logistic and linear regression approaches. To evaluate potential nonlinear patterns, restricted cubic spline (RCS) models were applied. Supplementary and robustness analyses encompassed receiver operating characteristic (ROC) curve evaluation, stratification by quartiles, subgroup comparisons, and handling of missing data via multiple imputation.

Results: Between 2011 and 2015, 610 participants developed weak handgrip strength. Among all TyG indices, only TyG-WHtR was significantly associated with grip strength indicators (absolute: β = -0.95, 95% CI: -1.56 and -0.33; relative: β = -0.06, 95% CI: -0.09 and -0.03; weak: OR = 1.34, 95% CI: 1.03 and 1.74). These associations remained robust when using cumulative TyG-WHtR. K-means clustering identified three TyG-WHtR trajectory subgroups. Compared to the stable low group, both moderate (β = -0.10) and sharply increasing groups (absolute: β = -1.19; relative: β = -0.15) showed a greater risk of muscle decline. ROC curves indicated similar diagnostic accuracy for baseline and cumulative TyG-WHtR.

Conclusions: Higher TyG-WHtR levels appear to be independently linked to poorer handgrip strength performance in midlife and elder adults. Maintaining a low TyG-WHtR may contribute to improving the health status of midlife and elderly adults by preserving handgrip strength.

目的:目前,研究肌肉力量与胰岛素抵抗之间关系的研究数量有限。本研究旨在探讨中国中老年人整体肌肉功能和健康衰老的公认指标——握力与基于甘油三酯-葡萄糖(TyG)的指标,包括TyG指数、TyG体重指数(TyG- bmi)、TyG腰围(TyG- wc)和TyG腰高比(TyG- whtr)之间的关系。方法:我们使用了2011年和2015年收集的中国健康与退休纵向研究(CHARLS)的队列,共包括3318名参与者。用绝对握力(用测力计测量)、相对握力(用BMI标准化的绝对握力)和定义的弱握力来评估握力。TyG指数及其衍生测量(TyG- bmi、TyG- wc和TyG- whtr)与不同握力结果之间的关系采用多变量逻辑回归和线性回归方法进行检验。为了评估潜在的非线性模式,使用了限制三次样条(RCS)模型。补充分析和稳健性分析包括受试者工作特征(ROC)曲线评估、四分位数分层、亚组比较以及通过多次插入处理缺失数据。结果:在2011年至2015年期间,610名参与者的握力变弱。在所有TyG指标中,只有TyG- whtr与握力指标显著相关(绝对值:β = -0.95, 95% CI: -1.56和-0.33;相对值:β = -0.06, 95% CI: -0.09和-0.03;弱值:OR = 1.34, 95% CI: 1.03和1.74)。当使用累积TyG-WHtR时,这些关联仍然很强。K-means聚类鉴定出三个TyG-WHtR轨迹亚组。与稳定低浓度组相比,中度(β = -0.10)和急剧升高组(绝对:β = -1.19;相对:β = -0.15)肌肉衰退的风险更大。ROC曲线显示基线和累积TyG-WHtR的诊断准确性相似。结论:较高的TyG-WHtR水平似乎与中年和老年人较差的握力表现独立相关。维持较低的TyG-WHtR可能通过保持握力来改善中老年人的健康状况。
{"title":"Relationship Between Triglyceride-Glucose Index and Handgrip Strength in the Midlife and Elderly Population: Evidence From a Chinese Cohort.","authors":"Zhaoliang Zhang, Yunfei Xu, Liehui Yao, Tao Ma, Liming Zhou","doi":"10.1155/ije/8838404","DOIUrl":"10.1155/ije/8838404","url":null,"abstract":"<p><strong>Aims: </strong>At present, only a limited number of studies have investigated the association between muscle strength and insulin resistance. This study aimed to investigate the relationship between handgrip strength, a recognized indicator of overall muscle function and healthy aging, and triglyceride-glucose (TyG)-based indicators, including the TyG index, TyG-body mass index (TyG-BMI), TyG-waist circumference (TyG-WC), and TyG-waist-to-height ratio (TyG-WHtR), among middle-aged and older Chinese adults.</p><p><strong>Methods: </strong>We utilized a cohort from the China Health and Retirement Longitudinal Study (CHARLS) collected in 2011 and 2015, comprising a total of 3318 participants. Handgrip strength was assessed using absolute handgrip strength (measured by dynamometers), relative handgrip strength (absolute handgrip strength standardized by BMI), and defined weak handgrip strength. The relationships between the TyG index and its derived measures (TyG-BMI, TyG-WC, and TyG-WHtR) and different grip strength outcomes were examined using both multivariable logistic and linear regression approaches. To evaluate potential nonlinear patterns, restricted cubic spline (RCS) models were applied. Supplementary and robustness analyses encompassed receiver operating characteristic (ROC) curve evaluation, stratification by quartiles, subgroup comparisons, and handling of missing data via multiple imputation.</p><p><strong>Results: </strong>Between 2011 and 2015, 610 participants developed weak handgrip strength. Among all TyG indices, only TyG-WHtR was significantly associated with grip strength indicators (absolute: <i>β</i> = -0.95, 95% CI: -1.56 and -0.33; relative: <i>β</i> = -0.06, 95% CI: -0.09 and -0.03; weak: OR = 1.34, 95% CI: 1.03 and 1.74). These associations remained robust when using cumulative TyG-WHtR. K-means clustering identified three TyG-WHtR trajectory subgroups. Compared to the stable low group, both moderate (<i>β</i> = -0.10) and sharply increasing groups (absolute: <i>β</i> = -1.19; relative: <i>β</i> = -0.15) showed a greater risk of muscle decline. ROC curves indicated similar diagnostic accuracy for baseline and cumulative TyG-WHtR.</p><p><strong>Conclusions: </strong>Higher TyG-WHtR levels appear to be independently linked to poorer handgrip strength performance in midlife and elder adults. Maintaining a low TyG-WHtR may contribute to improving the health status of midlife and elderly adults by preserving handgrip strength.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2025 ","pages":"8838404"},"PeriodicalIF":2.3,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12578554/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145431463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased Serum Lipopolysaccharide Levels are Related to a Higher Prevalent Risk of Subclinical Hypothyroidism. 血清脂多糖水平升高与亚临床甲状腺功能减退的较高流行风险相关。
IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-22 eCollection Date: 2025-01-01 DOI: 10.1155/ije/6332634
Xuan An, Xiaoyi Wang, Jin Zhang, Mingtong Xu, Muchao Wu

Background: This study aimed to assess the relationship between serum lipopolysaccharide levels and subclinical hypothyroidism in a southern Chinese adult population.

Methods: This cross-sectional community-based study included 2577 participants. Fasting venous samples were taken to examine lipopolysaccharide, thyroid hormone, thyroglobulin antibody, and thyroid peroxidase antibody levels. The population was divided into quartiles according to serum lipopolysaccharide levels. A multivariable-adjusted logistic regression model was applied to test the association between lipopolysaccharide and subclinical hypothyroidism.

Results: Participants with increased serum levels of lipopolysaccharide had a higher prevalence of Hashimoto's thyroiditis (Q1: 10.4%, Q2: 14.3%, Q3: 17.8%, and Q4: 29.5%; p-trend < 0.001) and subclinical hypothyroidism (Q1: 2.2%, Q2: 4.7%, Q3: 7.5%, and Q4: 13.4%; p-trend < 0.001). The multivariable-adjusted odds ratios for subclinical hypothyroidism in the 2nd, 3rd, and 4th serum lipopolysaccharide quartiles were 1.979 (95% CI: 1.033-3.793), 2.867 (95% CI: 1.534-5.360), and 4.091 (95% CI: 2.198-7.613), p-trend < 0.001, respectively, compared to the 1st quartile.

Conclusions: Increased serum lipopolysaccharide levels were related to an increased prevalence of subclinical hypothyroidism in the southern Chinese adult population.

背景:本研究旨在评估中国南方成年人血清脂多糖水平与亚临床甲状腺功能减退的关系。方法:以社区为基础的横断面研究纳入2577名参与者。空腹静脉取样检测脂多糖、甲状腺激素、甲状腺球蛋白抗体和甲状腺过氧化物酶抗体水平。根据血清脂多糖水平将人群分为四分位数。采用多变量调整logistic回归模型检验脂多糖与亚临床甲状腺功能减退之间的关系。结果:血清脂多糖水平升高的受试者桥本甲状腺炎患病率较高(Q1: 10.4%, Q2: 14.3%, Q3: 17.8%, Q4: 29.5%)。结论:血清脂多糖水平升高与中国南方成人亚临床甲状腺功能减退患病率升高有关。
{"title":"Increased Serum Lipopolysaccharide Levels are Related to a Higher Prevalent Risk of Subclinical Hypothyroidism.","authors":"Xuan An, Xiaoyi Wang, Jin Zhang, Mingtong Xu, Muchao Wu","doi":"10.1155/ije/6332634","DOIUrl":"10.1155/ije/6332634","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to assess the relationship between serum lipopolysaccharide levels and subclinical hypothyroidism in a southern Chinese adult population.</p><p><strong>Methods: </strong>This cross-sectional community-based study included 2577 participants. Fasting venous samples were taken to examine lipopolysaccharide, thyroid hormone, thyroglobulin antibody, and thyroid peroxidase antibody levels. The population was divided into quartiles according to serum lipopolysaccharide levels. A multivariable-adjusted logistic regression model was applied to test the association between lipopolysaccharide and subclinical hypothyroidism.</p><p><strong>Results: </strong>Participants with increased serum levels of lipopolysaccharide had a higher prevalence of Hashimoto's thyroiditis (Q1: 10.4%, Q2: 14.3%, Q3: 17.8%, and Q4: 29.5%; <i>p</i>-trend < 0.001) and subclinical hypothyroidism (Q1: 2.2%, Q2: 4.7%, Q3: 7.5%, and Q4: 13.4%; <i>p-</i>trend < 0.001). The multivariable-adjusted odds ratios for subclinical hypothyroidism in the 2nd, 3rd, and 4th serum lipopolysaccharide quartiles were 1.979 (95% CI: 1.033-3.793), 2.867 (95% CI: 1.534-5.360), and 4.091 (95% CI: 2.198-7.613), <i>p-</i>trend < 0.001, respectively, compared to the 1st quartile.</p><p><strong>Conclusions: </strong>Increased serum lipopolysaccharide levels were related to an increased prevalence of subclinical hypothyroidism in the southern Chinese adult population.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2025 ","pages":"6332634"},"PeriodicalIF":2.3,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12571524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145408835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bisphosphonate Therapy and the Occurrence of the Hungry Bone Syndrome After Surgery for Primary Hyperparathyroidism. 双膦酸盐治疗与原发性甲状旁腺功能亢进术后饥饿骨综合征的发生。
IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-21 eCollection Date: 2025-01-01 DOI: 10.1155/ije/8285521
Rahil Etemadi, Asieh Mansouri, Rezvan Salehidoost, Elham Tavousi Tabatabaei

Objective: Hungry bone syndrome (HBS), marked by severe and persistent hypocalcemia, frequently occurs after parathyroidectomy for primary hyperparathyroidism (PHPT). Despite its prevalence, there is limited research on this complication. This study aimed to assess the impact of preoperative bisphosphonate treatment on the incidence of postoperative HBS in PHPT patients.

Design: This retrospective study analyzed hospital records of patients with PHPT who underwent parathyroidectomy from January 2010 to January 2020.

Patients: The study included 144 patients with PHPT who underwent curative parathyroidectomy at AL-Zahra University Hospital within the specified timeframe. Patients with secondary or tertiary hyperparathyroidism or unsuccessful surgeries were excluded.

Measurements: Data on bisphosphonate use, clinical, and laboratory parameters were reviewed. Logistic regression analyzed the relationship between preoperative bisphosphonate treatment and the occurrence of postoperative HBS.

Results: Of the total of 144 patients, 19 received preoperative bisphosphonate therapy. The incidence of HBS was significantly higher in the bisphosphonate group (57.9%) compared to the nontreated group (11.2%) (p < 0.001). However, logistic regression analysis revealed no significant reduction in HBS occurrence due to bisphosphonate treatment, either in the overall cohort or in patients with moderate to severe hypercalcemia (calcium level ≥ 12 mg/dL) (odds ratio: 3.4, 95% CI: 0.5-22.7, p=0.191; odds ratio: 15.0, 95% CI: 0.6-383.9, p=0.102, respectively).

Conclusion: Preoperative bisphosphonate therapy does not prevent the development of HBS following parathyroidectomy for PHPT. Continuous postoperative calcium monitoring is essential for effective management and mitigation of HBS.

摘要目的:原发性甲状旁腺功能亢进(PHPT)患者行甲状旁腺切除术后,常发生以严重且持续的低钙血症为特征的饿骨综合征(HBS)。尽管其普遍存在,但对该并发症的研究有限。本研究旨在评估术前双膦酸盐治疗对PHPT患者术后HBS发生率的影响。设计:本回顾性研究分析了2010年1月至2020年1月期间接受甲状旁腺切除术的PHPT患者的医院记录。患者:该研究包括144例PHPT患者,他们在规定的时间内在AL-Zahra大学医院接受了治愈性甲状旁腺切除术。排除继发性或三期甲状旁腺功能亢进或手术失败的患者。测量:回顾了双膦酸盐使用、临床和实验室参数的数据。Logistic回归分析术前双膦酸盐治疗与术后HBS发生的关系。结果:144例患者中,19例术前接受了双膦酸盐治疗。双膦酸盐组HBS发生率(57.9%)显著高于未治疗组(11.2%)(p < 0.001)。然而,logistic回归分析显示,无论是在整个队列中,还是在中度至重度高钙血症(钙水平≥12 mg/dL)患者中,双膦酸盐治疗均未显著降低HBS的发生率(优势比:3.4,95% CI: 0.5-22.7, p=0.191;优势比:15.0,95% CI: 0.6-383.9, p=0.102)。结论:术前双膦酸盐治疗不能预防PHPT甲状旁腺切除术后HBS的发生。术后持续的钙监测是有效管理和缓解HBS的必要条件。
{"title":"Bisphosphonate Therapy and the Occurrence of the Hungry Bone Syndrome After Surgery for Primary Hyperparathyroidism.","authors":"Rahil Etemadi, Asieh Mansouri, Rezvan Salehidoost, Elham Tavousi Tabatabaei","doi":"10.1155/ije/8285521","DOIUrl":"10.1155/ije/8285521","url":null,"abstract":"<p><strong>Objective: </strong>Hungry bone syndrome (HBS), marked by severe and persistent hypocalcemia, frequently occurs after parathyroidectomy for primary hyperparathyroidism (PHPT). Despite its prevalence, there is limited research on this complication. This study aimed to assess the impact of preoperative bisphosphonate treatment on the incidence of postoperative HBS in PHPT patients.</p><p><strong>Design: </strong>This retrospective study analyzed hospital records of patients with PHPT who underwent parathyroidectomy from January 2010 to January 2020.</p><p><strong>Patients: </strong>The study included 144 patients with PHPT who underwent curative parathyroidectomy at AL-Zahra University Hospital within the specified timeframe. Patients with secondary or tertiary hyperparathyroidism or unsuccessful surgeries were excluded.</p><p><strong>Measurements: </strong>Data on bisphosphonate use, clinical, and laboratory parameters were reviewed. Logistic regression analyzed the relationship between preoperative bisphosphonate treatment and the occurrence of postoperative HBS.</p><p><strong>Results: </strong>Of the total of 144 patients, 19 received preoperative bisphosphonate therapy. The incidence of HBS was significantly higher in the bisphosphonate group (57.9%) compared to the nontreated group (11.2%) (<i>p</i> < 0.001). However, logistic regression analysis revealed no significant reduction in HBS occurrence due to bisphosphonate treatment, either in the overall cohort or in patients with moderate to severe hypercalcemia (calcium level ≥ 12 mg/dL) (odds ratio: 3.4, 95% CI: 0.5-22.7, <i>p</i>=0.191; odds ratio: 15.0, 95% CI: 0.6-383.9, <i>p</i>=0.102, respectively).</p><p><strong>Conclusion: </strong>Preoperative bisphosphonate therapy does not prevent the development of HBS following parathyroidectomy for PHPT. Continuous postoperative calcium monitoring is essential for effective management and mitigation of HBS.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2025 ","pages":"8285521"},"PeriodicalIF":2.3,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12566956/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145400885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Potential of Cynara scolymus Extract and Bifidobacterium longum in Alleviating Diabetes-Induced Male Reproductive Dysfunction. 长双歧杆菌和棘豆提取物对糖尿病性男性生殖功能障碍的治疗潜力。
IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-19 eCollection Date: 2025-01-01 DOI: 10.1155/ije/5884930
Hadis Bozorgpoursavadjani, Haniyeh Keyghobadi, Delaram Moghadam, Reza Zare, Farshad Dehghani, Iman Jamhiri, Farhad Koohpeyma, Sanaz Dastghaib

Background: Diabetes mellitus (DM) is associated with a number of adverse effects on male reproductive health, including oxidative stress, testosterone deficiency, and spermatogenesis defects. Natural and probiotic-based therapies have gained popularity as a means of alleviating DM-related complications.

Methods: Streptozotocin (60 mg/kg) was employed to induce diabetes in male Sprague-Dawley rats, which were then divided into eight groups, each receiving hydroalcoholic Cynara scolymus (Cynara) extract, Bifidobacterium longum (BBL) probiotic or a combination of both. The following parameters were measured: Fasting blood sugar (FBS), serum malondialdehyde (MDA), serum sexual hormones, and testicular MDA and total antioxidant capacity (TAC), as well as mRNA expressions of steroidogenesis enzymes Star, Cyp11a1, and Hsd17b3. Histopathological study and modified Johnson scoring system were performed.

Results: Rats with diabetes treated with Cynara, BBL, and their combination showed a substantial reduction in FBS and MDA levels as well as an increase in TAC when compared to the diabetic group. The combined treatment demonstrated a greater elevation in serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels in comparison to individual treatments. The mRNA expressions of Star, Cyp11a1, and Hsd17b3 increased significantly in the combined treatment group. Histological assessments revealed improved testicular architecture and germ cell populations in the combination therapy group.

Conclusion: Cynara and BBL treatments in diabetic rats in combination produced a powerful protective effect on male reproductive function. The results showed that Cynara and BBL could be considered as promising therapeutic agents able to reduce the detrimental effects of diabetes on male reproductive health. Further research is needed to define their precise mechanisms and potential clinical uses.

背景:糖尿病(DM)与男性生殖健康的许多不良影响有关,包括氧化应激、睾酮缺乏和精子发生缺陷。天然和以益生菌为基础的疗法作为缓解糖尿病相关并发症的一种手段已经得到了普及。方法:采用链脲佐菌素(60 mg/kg)诱导雄性sd - dawley大鼠糖尿病,将其分为8组,每组分别给予水合醇型脊柱双歧杆菌(Cynara scolymus, Cynara)提取物、长双歧杆菌(Bifidobacterium longum, BBL)益生菌或两者联合。测定各组空腹血糖(FBS)、血清丙二醛(MDA)、血清性激素、睾丸MDA和总抗氧化能力(TAC),以及甾体生成酶Star、Cyp11a1和Hsd17b3 mRNA表达量。进行组织病理学研究和改良的Johnson评分系统。结果:与糖尿病组相比,Cynara、BBL及其联合治疗的糖尿病大鼠FBS和MDA水平显著降低,TAC水平显著升高。与单独治疗相比,联合治疗显示血清黄体生成素(LH)、卵泡刺激素(FSH)和睾酮水平有更大的升高。联合治疗组Star、Cyp11a1、Hsd17b3 mRNA表达量显著升高。组织学评估显示,在联合治疗组改善睾丸结构和生殖细胞群。结论:Cynara和BBL联合用药对糖尿病大鼠的雄性生殖功能有较强的保护作用。结果表明,Cynara和BBL可被认为是有前景的治疗药物,可以减少糖尿病对男性生殖健康的不利影响。需要进一步的研究来确定它们的确切机制和潜在的临床应用。
{"title":"Therapeutic Potential of <i>Cynara scolymus</i> Extract and <i>Bifidobacterium longum</i> in Alleviating Diabetes-Induced Male Reproductive Dysfunction.","authors":"Hadis Bozorgpoursavadjani, Haniyeh Keyghobadi, Delaram Moghadam, Reza Zare, Farshad Dehghani, Iman Jamhiri, Farhad Koohpeyma, Sanaz Dastghaib","doi":"10.1155/ije/5884930","DOIUrl":"10.1155/ije/5884930","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus (DM) is associated with a number of adverse effects on male reproductive health, including oxidative stress, testosterone deficiency, and spermatogenesis defects. Natural and probiotic-based therapies have gained popularity as a means of alleviating DM-related complications.</p><p><strong>Methods: </strong>Streptozotocin (60 mg/kg) was employed to induce diabetes in male Sprague-Dawley rats, which were then divided into eight groups, each receiving hydroalcoholic <i>Cynara scolymus</i> (Cynara) extract, <i>Bifidobacterium longum</i> (BBL) probiotic or a combination of both. The following parameters were measured: Fasting blood sugar (FBS), serum malondialdehyde (MDA), serum sexual hormones, and testicular MDA and total antioxidant capacity (TAC), as well as mRNA expressions of steroidogenesis enzymes <i>Star</i>, <i>Cyp11a1</i>, and <i>Hsd17b3</i>. Histopathological study and modified Johnson scoring system were performed.</p><p><strong>Results: </strong>Rats with diabetes treated with <i>Cynara</i>, <i>BBL</i>, and their combination showed a substantial reduction in FBS and MDA levels as well as an increase in TAC when compared to the diabetic group. The combined treatment demonstrated a greater elevation in serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels in comparison to individual treatments. The mRNA expressions of <i>Star</i>, <i>Cyp11a1</i>, and <i>Hsd17b3</i> increased significantly in the combined treatment group. Histological assessments revealed improved testicular architecture and germ cell populations in the combination therapy group.</p><p><strong>Conclusion: </strong><i>Cynara</i> and <i>BBL</i> treatments in diabetic rats in combination produced a powerful protective effect on male reproductive function. The results showed that <i>Cynara</i> and <i>BBL</i> could be considered as promising therapeutic agents able to reduce the detrimental effects of diabetes on male reproductive health. Further research is needed to define their precise mechanisms and potential clinical uses.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2025 ","pages":"5884930"},"PeriodicalIF":2.3,"publicationDate":"2025-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12554919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145389092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid-Stimulating Hormone Regulates the Glucose Metabolism in Hepatocytes via Toll-Like Receptor 4/Tollip Pathway. 促甲状腺激素通过toll样受体4/Tollip通路调节肝细胞糖代谢
IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-15 eCollection Date: 2025-01-01 DOI: 10.1155/ije/5528193
Suqing Bao, Fengbo Li, Lijun Duan, Xia Jiang

Metabolic disorders are closely associated with thyroid dysfunction and the activity of thyroid-stimulating hormone (TSH). Previously, we found that subclinical hypothyroidism aggravates Toll-like receptor 4 (TLR4) signaling and interferes with glucose metabolism in rat liver tissue. Here, we explored the underlying mechanisms by which TSH affected TLR4 and glucose metabolism on hepatocytes in vitro. Hepatocytes were stimulated with TSH (0, 5, 10, and 20 mIU/mL) for 12 h and mRNA level of its receptor, thyroid-stimulating hormone receptor (TSHR), was increased. In contrast, glucose metabolism was blocked. After blocking TSHR, glucose metabolism in hepatocytes was rescued. Additionally, TSH treatment also activated TLRs signaling, and the expression of TLR4 and its downstream partners all decreased after TSHR was silenced, which indicated that TSH promotes TLR4 signaling through a TSHR-dependent mechanism. For the exploitation of the underlying relationship between TLR4 and glucose metabolism, siRNA was utilized to silence TLR4. After silencing TLR4, glucose metabolism was significantly rescued, which indicated that TLR4 was involved in the TSH-mediated downregulation of glucose metabolism in hepatocytes. Furthermore, as for the inhibitor of TLRs, Tollip was also measured. Under TSH treatment, the expression level of Tollip decreases. After silencing Tollip, TLR4 and its partners significantly increased and glucose metabolism was reduced. Our study indicated that TSH/TSHR regulated hepatocellular glucose metabolism via the TLR4/Tollip pathway.

代谢紊乱与甲状腺功能障碍和促甲状腺激素(TSH)活性密切相关。先前,我们发现亚临床甲状腺功能减退可加重toll样受体4 (TLR4)信号传导并干扰大鼠肝组织的糖代谢。在此,我们探讨了TSH影响肝细胞TLR4和糖代谢的潜在机制。用TSH(0、5、10和20 mIU/mL)刺激肝细胞12小时,其受体促甲状腺激素受体(TSHR) mRNA水平升高。相反,葡萄糖代谢被阻断。阻断TSHR后,肝细胞的糖代谢得到恢复。此外,TSH处理还激活了TLRs信号,TSHR沉默后,TLR4及其下游伙伴的表达均下降,表明TSH通过TSHR依赖机制促进TLR4信号转导。为了揭示TLR4与葡萄糖代谢之间的潜在关系,我们利用siRNA沉默TLR4。TLR4沉默后,糖代谢明显恢复,说明TLR4参与了tsh介导的肝细胞糖代谢下调。此外,对TLRs的抑制剂也进行了Tollip测定。在TSH处理下,Tollip的表达水平降低。沉默Tollip后,TLR4及其伴体显著升高,糖代谢降低。我们的研究表明,TSH/TSHR通过TLR4/Tollip通路调节肝细胞糖代谢。
{"title":"Thyroid-Stimulating Hormone Regulates the Glucose Metabolism in Hepatocytes via Toll-Like Receptor 4/Tollip Pathway.","authors":"Suqing Bao, Fengbo Li, Lijun Duan, Xia Jiang","doi":"10.1155/ije/5528193","DOIUrl":"10.1155/ije/5528193","url":null,"abstract":"<p><p>Metabolic disorders are closely associated with thyroid dysfunction and the activity of thyroid-stimulating hormone (TSH). Previously, we found that subclinical hypothyroidism aggravates Toll-like receptor 4 (TLR4) signaling and interferes with glucose metabolism in rat liver tissue. Here, we explored the underlying mechanisms by which TSH affected TLR4 and glucose metabolism on hepatocytes in vitro. Hepatocytes were stimulated with TSH (0, 5, 10, and 20 mIU/mL) for 12 h and mRNA level of its receptor, thyroid-stimulating hormone receptor (TSHR), was increased. In contrast, glucose metabolism was blocked. After blocking TSHR, glucose metabolism in hepatocytes was rescued. Additionally, TSH treatment also activated TLRs signaling, and the expression of TLR4 and its downstream partners all decreased after TSHR was silenced, which indicated that TSH promotes TLR4 signaling through a TSHR-dependent mechanism. For the exploitation of the underlying relationship between TLR4 and glucose metabolism, siRNA was utilized to silence TLR4. After silencing TLR4, glucose metabolism was significantly rescued, which indicated that TLR4 was involved in the TSH-mediated downregulation of glucose metabolism in hepatocytes. Furthermore, as for the inhibitor of TLRs, Tollip was also measured. Under TSH treatment, the expression level of Tollip decreases. After silencing Tollip, TLR4 and its partners significantly increased and glucose metabolism was reduced. Our study indicated that TSH/TSHR regulated hepatocellular glucose metabolism via the TLR4/Tollip pathway.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2025 ","pages":"5528193"},"PeriodicalIF":2.3,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12543453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145354736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neu-P11 Improves Type 2 Diabetes Mellitus Immune Function by Inhibiting the Hippo Signaling Pathway. Neu-P11通过抑制Hippo信号通路改善2型糖尿病免疫功能
IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-13 eCollection Date: 2025-01-01 DOI: 10.1155/ije/3385546
Shichang Cai, Si-Ke Qi, Li-Na Mao, Liu Xie, Juan He, Ying-Zhuo Li, Xiu-Ping Li

Objective: Melatonin (Mel) plays a significant role in maintaining bodily homeostasis and regulating insulin resistance (IR) associated with Type 2 diabetes mellitus (T2DM). Neu-P11 is a novel Mel receptor agonist that has been reported to play a critical role in immune function in T2DM. This study aims to investigate the impact of Neu-P11 on the immune function in individuals with T2DM and its potential regulatory pathways.

Material and methods: After inducing IR in 3T3-L1 cells, the study examined the impact of piromelatine (Neu-P11) and XMU-MP-1 (a Hippo pathway inhibitor) on the levels of Hippo pathway proteins, cell viability, extracellular glucose, and GLUT4 expression. After establishing T2DM in rats by a high-fat diet and streptomycin, the effects of Neu-P11 and XMU-MP-1 on glucose metabolism and serum levels of insulin, IgA, IgG, and IgM were investigated. Primary splenocytes isolated from experimental rats were analyzed for the number of immune cells and reactive oxygen species (ROS).

Results: In our study, Mel, Neu-P11, and XMU-MP-1 reduced the levels of phospho-MST1/2, phospho-LATS1/LATS1, phospho-YAP/YAP, and phospho-TAZ/TAZ in the Hippo pathway and enhanced cell viability and glucose uptake capability. This effect was more evident in the Neu-P11+XMU-MP-1 group. After treatment with Mel, Neu-P11, and XMU-MP-1, respectively, T2DM rats showed slower weight gain and a decreased spleen index, suppressed splenic ROS, downregulated phosphorylated Hippo pathway proteins, decreased IgA, and increased IgG and IgM, with improved glucose and insulin tolerance. Mel, Neu-P11, and XMU-MP-1 increased the immune cell number (CD3+, CD16+, and CD19+) in T2DM rats. Notably, co-treatment of Neu-P11 and XMU-MP-1 demonstrated superior restoration across all parameters, indicating the efficacy of combinatorial targeting.

Conclusion: Neu-P11 improves immune function and increases insulin sensitivity in T2DM by inhibiting the Hippo signaling pathway, offering a novel therapeutic avenue for T2DM.

目的:褪黑素(Melatonin, Mel)在2型糖尿病(T2DM)患者体内维持稳态和调节胰岛素抵抗(insulin resistance, IR)中发挥重要作用。new - p11是一种新型的Mel受体激动剂,据报道在T2DM患者的免疫功能中起关键作用。本研究旨在探讨Neu-P11对T2DM患者免疫功能的影响及其潜在的调控途径。材料和方法:在3T3-L1细胞中诱导IR后,本研究检测了吡洛美拉丁(Neu-P11)和XMU-MP-1(一种Hippo通路抑制剂)对Hippo通路蛋白水平、细胞活力、细胞外葡萄糖和GLUT4表达的影响。通过高脂饮食和链霉素建立T2DM大鼠后,研究了Neu-P11和XMU-MP-1对糖代谢和血清胰岛素、IgA、IgG、IgM水平的影响。分析实验大鼠原代脾细胞免疫细胞和活性氧(ROS)的数量。结果:在我们的研究中,Mel、new - p11和XMU-MP-1降低了Hippo通路中phospho-MST1/2、phospho-LATS1/LATS1、phospho-YAP/YAP和phospho-TAZ/TAZ的水平,增强了细胞活力和葡萄糖摄取能力。这种作用在nue - p11 +XMU-MP-1组中更为明显。分别给予Mel、new - p11和XMU-MP-1治疗后,T2DM大鼠体重增加减慢,脾脏指数下降,脾脏ROS抑制,Hippo通路磷酸化蛋白下调,IgA降低,IgG和IgM升高,葡萄糖和胰岛素耐量改善。Mel、Neu-P11和XMU-MP-1增加T2DM大鼠的免疫细胞数量(CD3+、CD16+和CD19+)。值得注意的是,nu - p11和XMU-MP-1联合治疗在所有参数上都表现出更好的恢复,表明联合靶向的有效性。结论:Neu-P11通过抑制Hippo信号通路改善T2DM患者的免疫功能,提高胰岛素敏感性,为T2DM的治疗提供了新的途径。
{"title":"Neu-P11 Improves Type 2 Diabetes Mellitus Immune Function by Inhibiting the Hippo Signaling Pathway.","authors":"Shichang Cai, Si-Ke Qi, Li-Na Mao, Liu Xie, Juan He, Ying-Zhuo Li, Xiu-Ping Li","doi":"10.1155/ije/3385546","DOIUrl":"10.1155/ije/3385546","url":null,"abstract":"<p><strong>Objective: </strong>Melatonin (Mel) plays a significant role in maintaining bodily homeostasis and regulating insulin resistance (IR) associated with Type 2 diabetes mellitus (T2DM). Neu-P11 is a novel Mel receptor agonist that has been reported to play a critical role in immune function in T2DM. This study aims to investigate the impact of Neu-P11 on the immune function in individuals with T2DM and its potential regulatory pathways.</p><p><strong>Material and methods: </strong>After inducing IR in 3T3-L1 cells, the study examined the impact of piromelatine (Neu-P11) and XMU-MP-1 (a Hippo pathway inhibitor) on the levels of Hippo pathway proteins, cell viability, extracellular glucose, and GLUT4 expression. After establishing T2DM in rats by a high-fat diet and streptomycin, the effects of Neu-P11 and XMU-MP-1 on glucose metabolism and serum levels of insulin, IgA, IgG, and IgM were investigated. Primary splenocytes isolated from experimental rats were analyzed for the number of immune cells and reactive oxygen species (ROS).</p><p><strong>Results: </strong>In our study, Mel, Neu-P11, and XMU-MP-1 reduced the levels of phospho-MST1/2, phospho-LATS1/LATS1, phospho-YAP/YAP, and phospho-TAZ/TAZ in the Hippo pathway and enhanced cell viability and glucose uptake capability. This effect was more evident in the Neu-P11+XMU-MP-1 group. After treatment with Mel, Neu-P11, and XMU-MP-1, respectively, T2DM rats showed slower weight gain and a decreased spleen index, suppressed splenic ROS, downregulated phosphorylated Hippo pathway proteins, decreased IgA, and increased IgG and IgM, with improved glucose and insulin tolerance. Mel, Neu-P11, and XMU-MP-1 increased the immune cell number (CD3+, CD16+, and CD19+) in T2DM rats. Notably, co-treatment of Neu-P11 and XMU-MP-1 demonstrated superior restoration across all parameters, indicating the efficacy of combinatorial targeting.</p><p><strong>Conclusion: </strong>Neu-P11 improves immune function and increases insulin sensitivity in T2DM by inhibiting the Hippo signaling pathway, offering a novel therapeutic avenue for T2DM.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2025 ","pages":"3385546"},"PeriodicalIF":2.3,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145345202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship Between BMI and Prediabetes in Chinese Adults: A Cross-Sectional Analytical Study. BMI与中国成人前驱糖尿病关系的横断面分析研究
IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-13 eCollection Date: 2025-01-01 DOI: 10.1155/ije/5524318
Beibei Luo, Wenbo Xu, Dan Ye

Introduction: Prediabetes represents a critical stage in the progression towards diabetes. However, there is a scarcity of studies examining the specific impact of body mass index (BMI) on prediabetes risk among the Chinese population. This study aims to analyze the association between BMI and the risk of prediabetes in Chinese adults.

Methods: In this cross-sectional analytical study, we analyzed data from 11,847 participants in the China Health and Retirement Longitudinal Study (CHARLS) conducted in 2011. For both univariate and multivariate analyses, logistic regression models were employed. Using a BMI range of 18.5-23.9 kg/m2 as the reference, we calculated the odds ratio (OR) and 95% confidence interval (95% CI) for different BMI categories and their associated outcomes.

Results: Significant differences were observed in the distribution of variables such as gender, age, education level, marital status, smoking and drinking habits, systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference (WC), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), hypertension, dyslipidemia, heart disease, kidney disease, and prediabetes across different BMI groups (p < 0.05). Furthermore, when BMI was treated as a continuous variable, curve fitting analysis indicated that the risk of prediabetes increased when BMI exceeded 22.9 kg/m2.

Conclusion: Obesity is a significant risk factor for prediabetes, with the prevalence of prediabetes increasing among overweight and obese individuals in China.

前驱糖尿病是糖尿病发展的关键阶段。然而,在中国人群中,身体质量指数(BMI)对前驱糖尿病风险的具体影响的研究很少。本研究旨在分析中国成人BMI与前驱糖尿病风险之间的关系。方法:在这项横断面分析研究中,我们分析了2011年中国健康与退休纵向研究(CHARLS)中11,847名参与者的数据。单因素和多因素分析均采用logistic回归模型。以18.5-23.9 kg/m2的BMI范围为参考,我们计算了不同BMI类别及其相关结局的比值比(OR)和95%置信区间(95% CI)。结果:显著差异分布的观察变量,如性别、年龄、教育程度、婚姻状况、吸烟和饮酒习惯,收缩压(SBP)、舒张压(菲律宾)、腰围(WC)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(hdl - c)、低密度脂蛋白胆固醇(低密度脂蛋白),空腹血浆葡萄糖(台塑)、糖化血红蛋白(HbA1c),高血压、高血脂、心脏病、肾病,不同BMI组间糖尿病前期差异(p < 0.05)。此外,当BMI作为连续变量时,曲线拟合分析表明,当BMI超过22.9 kg/m2时,前驱糖尿病的风险增加。结论:肥胖是前驱糖尿病的重要危险因素,中国超重和肥胖人群的前驱糖尿病患病率呈上升趋势。
{"title":"Relationship Between BMI and Prediabetes in Chinese Adults: A Cross-Sectional Analytical Study.","authors":"Beibei Luo, Wenbo Xu, Dan Ye","doi":"10.1155/ije/5524318","DOIUrl":"10.1155/ije/5524318","url":null,"abstract":"<p><strong>Introduction: </strong>Prediabetes represents a critical stage in the progression towards diabetes. However, there is a scarcity of studies examining the specific impact of body mass index (BMI) on prediabetes risk among the Chinese population. This study aims to analyze the association between BMI and the risk of prediabetes in Chinese adults.</p><p><strong>Methods: </strong>In this cross-sectional analytical study, we analyzed data from 11,847 participants in the China Health and Retirement Longitudinal Study (CHARLS) conducted in 2011. For both univariate and multivariate analyses, logistic regression models were employed. Using a BMI range of 18.5-23.9 kg/m<sup>2</sup> as the reference, we calculated the odds ratio (OR) and 95% confidence interval (95% CI) for different BMI categories and their associated outcomes.</p><p><strong>Results: </strong>Significant differences were observed in the distribution of variables such as gender, age, education level, marital status, smoking and drinking habits, systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference (WC), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), hypertension, dyslipidemia, heart disease, kidney disease, and prediabetes across different BMI groups (<i>p</i> < 0.05). Furthermore, when BMI was treated as a continuous variable, curve fitting analysis indicated that the risk of prediabetes increased when BMI exceeded 22.9 kg/m<sup>2</sup>.</p><p><strong>Conclusion: </strong>Obesity is a significant risk factor for prediabetes, with the prevalence of prediabetes increasing among overweight and obese individuals in China.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2025 ","pages":"5524318"},"PeriodicalIF":2.3,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537145/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145344850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally Invasive Thermal Ablation for Papillary Thyroid Microcarcinoma: Feasibility Analysis in Primary Healthcare Settings. 微创热消融治疗甲状腺乳头状微癌:在初级医疗机构的可行性分析。
IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-10 eCollection Date: 2025-01-01 DOI: 10.1155/ije/1475199
Shaotian Li, Shanshan Hu, Xiaoli Zheng, Xiong Ku, Jingfeng Zou, Liping Wang, Guqiao Nie, Yiting Liu, Chunhui Tian, Jiajia Ran, Xin Yang, Mi Yan, Yilan Yin, Yun Liu, Jingjing Wan, Wen Peng

Thyroid tumors are the most prevalent malignant neoplasms of the endocrine system, with an incidence approximately ten times higher than that of other endocrine tumors, accounting for 0.2%-1.0% of all malignant tumors (Zhu and Zhang, 2012 and Liu and Liao, 2017). Papillary thyroid microcarcinoma (PTMC) is a distinct subtype of papillary thyroid carcinoma (PTC), characterized by a maximum diameter of ≤ 10 mm. In recent decades, the incidence of PTC has tripled (Howlader, 2020). According to the 2014 World Health Organization (WHO) cancer report, over 50% of newly diagnosed thyroid cancer cases are PTMC (Soares et al., 2014). Furthermore, advancements in ultrasound (US) diagnostic techniques and the widespread adoption of US-guided fine-needle aspiration biopsy (US-FNAB) have led to a continued rise in the detection rate of PTMC (Bi, 2019). Among the various treatment modalities for PTMC, minimally invasive thermal ablation techniques offer substantial advantages over traditional surgical interventions, including enhanced safety, efficacy, minimal invasiveness, improved cosmetic outcomes, cost-effectiveness, ease of operation, and reduced anesthesia requirements. Moreover, these procedures are not confined to operating rooms and can be effectively performed in outpatient settings. Given these benefits, thermal ablation techniques hold great promise for widespread adoption in primary healthcare settings in China (primary healthcare facilities are critical for equitable access in resource-limited regions), as they not only reduce patient treatment costs but also optimize healthcare resource allocation, aligning with the national hierarchical medical system reform. This study aims to assess the feasibility of promoting the application of minimally invasive thermal ablation for PTMC in primary healthcare settings.

甲状腺肿瘤是内分泌系统最常见的恶性肿瘤,其发病率约为其他内分泌肿瘤的10倍,占所有恶性肿瘤的0.2%-1.0% (Zhu and Zhang, 2012; Liu and Liao, 2017)。甲状腺乳头状微癌(PTMC)是甲状腺乳头状癌(PTC)的一个独特亚型,其特征是最大直径≤10 mm。近几十年来,PTC的发病率增加了两倍(Howlader, 2020)。根据2014年世界卫生组织(WHO)癌症报告,超过50%的新诊断甲状腺癌病例是PTMC (Soares et al., 2014)。此外,超声(US)诊断技术的进步和超声引导的细针穿刺活检(US- fnab)的广泛采用导致PTMC的检出率持续上升(Bi, 2019)。在PTMC的各种治疗方式中,微创热消融技术比传统的手术干预具有显著的优势,包括增强安全性、有效性、微创性、改善美容效果、成本效益、易于操作和减少麻醉需求。此外,这些程序不局限于手术室,可以有效地执行门诊设置。鉴于这些好处,热消融技术在中国的初级卫生保健机构(初级卫生保健设施对于资源有限地区的公平获取至关重要)中具有广泛应用的巨大前景,因为它们不仅降低了患者的治疗成本,而且优化了医疗资源配置,与国家分级医疗体系改革相一致。本研究旨在评估微创热消融在基层医疗机构推广应用PTMC的可行性。
{"title":"Minimally Invasive Thermal Ablation for Papillary Thyroid Microcarcinoma: Feasibility Analysis in Primary Healthcare Settings.","authors":"Shaotian Li, Shanshan Hu, Xiaoli Zheng, Xiong Ku, Jingfeng Zou, Liping Wang, Guqiao Nie, Yiting Liu, Chunhui Tian, Jiajia Ran, Xin Yang, Mi Yan, Yilan Yin, Yun Liu, Jingjing Wan, Wen Peng","doi":"10.1155/ije/1475199","DOIUrl":"10.1155/ije/1475199","url":null,"abstract":"<p><p>Thyroid tumors are the most prevalent malignant neoplasms of the endocrine system, with an incidence approximately ten times higher than that of other endocrine tumors, accounting for 0.2%-1.0% of all malignant tumors (Zhu and Zhang, 2012 and Liu and Liao, 2017). Papillary thyroid microcarcinoma (PTMC) is a distinct subtype of papillary thyroid carcinoma (PTC), characterized by a maximum diameter of ≤ 10 mm. In recent decades, the incidence of PTC has tripled (Howlader, 2020). According to the 2014 World Health Organization (WHO) cancer report, over 50% of newly diagnosed thyroid cancer cases are PTMC (Soares et al., 2014). Furthermore, advancements in ultrasound (US) diagnostic techniques and the widespread adoption of US-guided fine-needle aspiration biopsy (US-FNAB) have led to a continued rise in the detection rate of PTMC (Bi, 2019). Among the various treatment modalities for PTMC, minimally invasive thermal ablation techniques offer substantial advantages over traditional surgical interventions, including enhanced safety, efficacy, minimal invasiveness, improved cosmetic outcomes, cost-effectiveness, ease of operation, and reduced anesthesia requirements. Moreover, these procedures are not confined to operating rooms and can be effectively performed in outpatient settings. Given these benefits, thermal ablation techniques hold great promise for widespread adoption in primary healthcare settings in China (primary healthcare facilities are critical for equitable access in resource-limited regions), as they not only reduce patient treatment costs but also optimize healthcare resource allocation, aligning with the national hierarchical medical system reform. This study aims to assess the feasibility of promoting the application of minimally invasive thermal ablation for PTMC in primary healthcare settings.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2025 ","pages":"1475199"},"PeriodicalIF":2.3,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12534144/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1